Neutrophil-to-lymphocyte ratio as a predictive indicator of the response to nivolumab in oral squamous cell carcinoma

被引:0
|
作者
Tachinami, Hidetake [1 ]
Tomihara, Kei [2 ]
Yamada, Shinichi [1 ]
Miyazaki, Akihiro [3 ]
Hayashi, Ryuji [4 ]
Noguchi, Makoto [1 ]
机构
[1] Toyama Univ, Dept Oral Maxiilofac Surg, Toyama, Japan
[2] Niigata Univ, Div Oral Maxiilofac Surg, Niigata, Japan
[3] Sapporo Med Univ, Dept Oral Maxiilofac Surg, Sapporo, Hokkaido, Japan
[4] Toyama Univ, Dept Clin Oncol, Toyama, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-1285
引用
收藏
页码:650 / 650
页数:1
相关论文
共 50 条
  • [1] Neutrophil-to-lymphocyte ratio as a predictive indicator of the response to nivolumab in oral squamous cell carcinoma
    Tachinami, Hidetake
    Tomihara, Kei
    Sakurai, Kotaro
    Noguchi, Makoto
    CANCER SCIENCE, 2022, 113 : 1747 - 1747
  • [2] Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma
    Rosculet, Nicholas
    Zhou, Xian Chong
    Ha, Patrick
    Tang, Mei
    Levine, Marshall A.
    Neuner, Geoffrey
    Califano, Joseph
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (04): : 662 - 667
  • [3] NEUTROPHIL-TO-LYMPHOCYTE RATIO AS A PREDICTIVE BIOMARKER FOR RESPONSE TO NIVOLUMAB IN ASIAN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Bando, Yukari
    Sakamoto, Mariko
    Okamura, Yasuyoshi
    Suzuki, Kotaro
    Hara, Takuto
    Terakawa, Tomoaki
    Furukawa, Junya
    Harada, Kenichi
    Hinata, Nobuyuki
    Nakano, Yuzo
    Fujisawa, Masato
    JOURNAL OF UROLOGY, 2019, 201 (04): : E344 - E345
  • [4] Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab
    Tachinami, Hidetake
    Tomihara, Kei
    Yamada, Shin-ichi
    Ikeda, Atsushi
    Imaue, Shuichi
    Hirai, Hideaki
    Nakai, Hiromi
    Sonoda, Tomoko
    Kurohara, Kazuto
    Yoshioka, Yukio
    Hasegawa, Takumi
    Naruse, Tomofumi
    Niiyama, Takashi
    Shimane, Tetsu
    Ueda, Michihiro
    Yanamoto, Souichi
    Akashi, Masaya
    Umeda, Masahiro
    Kurita, Hiroshi
    Miyazaki, Akihiro
    Arai, Naoya
    Hayashi, Ryuji
    Noguchi, Makoto
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2023, 61 (04): : 320 - 326
  • [5] The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma
    Chen, Miao-Fen
    Chen, Ping-Tsung
    Kuan, Feng-Che
    Chen, Wen-Cheng
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (01) : 190 - 199
  • [6] The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma
    Miao-Fen Chen
    Ping-Tsung Chen
    Feng-Che Kuan
    Wen-Cheng Chen
    Annals of Surgical Oncology, 2019, 26 : 190 - 199
  • [7] Neutrophil-to-lymphocyte Ratio: A Surrogate Marker for Prognosis of Oral Squamous Cell Carcinoma
    Mahalakshmi, R.
    Boaz, Karen
    Srikant, N.
    Baliga, Mohan
    Shetty, Premalatha
    Prasad, Mukul
    Yellapurkar, Shweta
    Lewis, Amitha J.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2018, 39 (01) : 8 - 12
  • [8] Neutrophil-to-Lymphocyte Ratio and Pembrolizumab Outcomes in Oral Cavity Squamous Cell Carcinoma
    Truong, Angeline A.
    Lee, Rex H.
    Wu, Xin
    Algazi, Alain P.
    Kang, Hyunseok
    El-Sayed, Ivan H.
    George, Jonathan R.
    Heaton, Chase M.
    Ryan, William R.
    Jeon, Yena
    Kim, Mi-Ok
    Ha, Patrick K.
    Wai, Katherine C.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2025, 172 (02) : 548 - 555
  • [10] Significance of the neutrophil-to-lymphocyte ratio in young patients with oral squamous cell carcinoma
    Zhang, Baixia
    Du, Wei
    Gan, Kang
    Fang, Qigen
    Zhang, Xu
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7597 - 7603